Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 265-270, January 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okubo, A.
Right arrow Articles by Ogura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okubo, A.
Right arrow Articles by Ogura, T.

Membrane-associated Interleukin 1{alpha} as a Mediator of Tumor Cell Killing by Human Blood Monocytes Fixed with Paraformaldehyde1

Akio Okubo, Saburo Sone2, Makoto Tanaka and Takeshi Ogura

The 3rd Department of Internal Medicine, The University of Tokushima School of Medicine, Kuramoto-cho 3, Tokushima 770, Japan

Human blood monocytes isolated by centrifugal elutriation from healthy donors were tested for ability to produce membrane-associated antitumor monokine(s) in response to activation stimuli such as various types of interferon (IFN) and/or synthetic desmethyl muramyl dipeptide (norMDP). IFNs ({alpha}, ß, and {gamma}) and norMDP rendered blood monocytes cytotoxic to allogeneic A375 melanoma cells, as assayed by measuring release of [125I]iododeoxyuridine in 72 h. When monocytes were treated with any type of IFN for 16 h, and then fixed with paraformaldehyde, they did not show cytotoxicity to A375 cells, but when they were fixed after treatment with norMDP or lipopolysaccharide they showed significant cytotoxicity to A375 melanoma cells. This membrane-associated antitumor monokine induced by the synergistic actions of suboptimal concentrations of IFN-{gamma} and norMDP, was cytotoxic to HT-29 colon cancer cells as well as A375 melanoma cells, but not to actinomycin D-treated L-929 cells. The fixed monocyte-mediated cytotoxicity against A375 melanoma cells was completely inhibited by a specific anti-interleukin 1{alpha} antiserum, but not by a specific anti-interleukin 1ß antiserum or monoclonal anti-TNF antibody. These results suggest that membrane-associated interleukin 1{alpha} is involved through cell-to-cell contact in the host defense mechanism against cancer.

1 Research sponsored by a Grant-in-Aid for Cancer Research from the Ministry of Education, Science, and Culture, and a grant from the Ministry of Health and Welfare of Japan.

2 To whom requests for reprints should be addressed.

Received 3/25/88. Revised 6/27/88. Revised 8/11/88. Revised 10/ 3/88. Accepted 10/13/88.




This article has been cited by other articles:


Home page
Cancer Res.Home page
K. Tsung, J. P. Dolan, Y. L. Tsung, and J. A. Norton
Macrophages as Effector Cells in Interleukin 12-induced T Cell-dependent Tumor Rejection
Cancer Res., September 1, 2002; 62(17): 5069 - 5075.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.